C

Cannara Biotech Inc
XTSX:LOVE

Watchlist Manager
Cannara Biotech Inc
XTSX:LOVE
Watchlist
Price: 1.7 CAD 0.59% Market Closed
Market Cap: 161.3m CAD

Cannara Biotech Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Cannara Biotech Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Cannara Biotech Inc
XTSX:LOVE
Operating Income
-CA$7.8m
CAGR 3-Years
-8%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Operating Income
$2.1B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
-2%
Canopy Growth Corp
TSX:WEED
Operating Income
-CA$62.2m
CAGR 3-Years
54%
CAGR 5-Years
41%
CAGR 10-Years
-18%
Sundial Growers Inc
NASDAQ:SNDL
Operating Income
-CA$11.5m
CAGR 3-Years
39%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Operating Income
-$19.7m
CAGR 3-Years
46%
CAGR 5-Years
35%
CAGR 10-Years
-33%
K
Knight Therapeutics Inc
TSX:GUD
Operating Income
-CA$11.5m
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
-1%
No Stocks Found

Cannara Biotech Inc
Glance View

Market Cap
155.4m CAD
Industry
Pharmaceuticals

Cannara Biotech, Inc. is a pharmaceutical company, which operates cannabis biotech facility. The company is headquartered in Montreal, Quebec. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. Its segments include Indoor cannabis operations and Real estate operations. The Indoor cannabis operations segment includes the cultivation, processing and sale of dried cannabis and cannabis derivatives exclusively for the Quebec and Canadian market. The Real estate operations segment is related to the Farnham building. The Company, through ShopCBD.com Inc., operates an online e-commerce platform in the United States hemp-based Cannabidiol (CBD) market. The firm sells dried cannabis products to provincial retail distributors and other licensed producers across Canada through Cannara Biotech (Quebec) Inc. The company owns approximately two cultivation facilities based in Quebec spanning over 1,650,000 square feet.

LOVE Intrinsic Value
HIDDEN
Show

See Also

What is Cannara Biotech Inc's Operating Income?
Operating Income
-7.8m CAD

Based on the financial report for Aug 31, 2025, Cannara Biotech Inc's Operating Income amounts to -7.8m CAD.

What is Cannara Biotech Inc's Operating Income growth rate?
Operating Income CAGR 5Y
7%

Over the last year, the Operating Income growth was 55%. The average annual Operating Income growth rates for Cannara Biotech Inc have been -8% over the past three years , 7% over the past five years .

Back to Top